Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Colorado by County

Prostate (Late Stage^), 2015-2019

All Races (includes Hispanic), Male, All Ages

Sorted by Name

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Colorado6


US (SEER+NPCR)1


Weld County6


Teller County6


Summit County6


Routt County6


Pueblo County6


Pitkin County6


Morgan County6


Montrose County6


Montezuma County6


Mesa County6


Logan County6


Larimer County6


La Plata County6


Jefferson County6


Gunnison County6


Garfield County6


Fremont County6


Elbert County6


El Paso County6


Eagle County6


Douglas County6


Denver County6


Delta County6


Chaffee County6


Broomfield County6


Boulder County6


Arapahoe County6


Adams County6


Alamosa County6 Archuleta County6 Baca County6 Bent County6 Cheyenne County6 Clear Creek County6 Conejos County6 Costilla County6 Crowley County6 Custer County6 Dolores County6 Gilpin County6 Grand County6 Hinsdale County6 Huerfano County6 Jackson County6 Kiowa County6 Kit Carson County6 Lake County6 Las Animas County6 Lincoln County6 Mineral County6 Moffat County6 Otero County6 Ouray County6 Park County6 Phillips County6 Prowers County6 Rio Blanco County6 Rio Grande County6 Saguache County6 San Juan County6 San Miguel County6 Sedgwick County6 Washington County6 Yuma County6

Notes:
Created by statecancerprofiles.cancer.gov on 11/30/2022 4:51 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.